Effects of Pretreatment with Different Doses of Lidocaine on Injection Pain

NCT06865300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2025-03-07

No results posted yet for this study

Summary

One of the medications administered to patients in general anesthesia practice is rocuronium, which causes pain during intravenous administration. It is known that a drug containing lidocaine as the active ingredient can reduce the pain caused by rocuronium in different doses. The effective dose of lidocaine remains a topic of debate. In our study, we aimed to investigate the efficacy of two different doses of lidocaine. No adverse effects are expected from this medication.

Conditions

  • Rocuronium Adverse Reaction
  • Lidocaine Adverse Reaction

Interventions

DRUG

Lidocain 40 mg

We injected 40 mg lidocain before rocuronium injection. Then we recorded pain score by using visual analog scale.

DRUG

lidocain 1 mg/kg

We injected 1 mg/kg lidocain before rocuronium injection. Then we recorded pain score by using visual analog scale.

DRUG

serum physiologic

We injected serum physiologic before rocuronium injection. Then we recorded pain score by using visual analog scale.

Sponsors & Collaborators

  • Giresun University

    lead OTHER

Principal Investigators

  • Azime Bulut · Giresun University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-10-31
Completion
2023-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06865300 on ClinicalTrials.gov